Effects of levodopa oral bolus on the kinematics of the pointing movements in Parkinson’s disease patients
✍ Scribed by R. Camarda; C. Camarda; S. Grimaldi; L. K. C. Camarda; R. Monastero; M. Gangitano
- Publisher
- Springer
- Year
- 2005
- Tongue
- English
- Weight
- 478 KB
- Volume
- 252
- Category
- Article
- ISSN
- 0340-5354
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract We examined the effects of levodopa and unilateral pallidotomy on quantitative measures of walking and reaching in Parkinson's disease (PD). We also compared quantitative measures of movement with standard clinical rating scales. We used kinematic measures and the Unified Parkinson's Di
## Abstract Homocysteine (Hcy) is a risk factor for vascular diseases, cognitive impairment, and dementia. Elevated plasma concentrations of Hcy have been found recently in Parkinson's disease (PD) patients treated with levodopa, suggesting that levodopa is a cause of hyperhomocysteinemia (HHcy). T
Author roles: Conception and design (Espay, Lang, Chen), data acquisition (Espay, Chen), drafting (Espay), editing and revising of the text (Lang, Chen).
## Abstract Performance of repetitive hand movements in patients with Parkinson's disease (PD) is characterized by slowness, reduced movement amplitude, and hesitation or arrests in ongoing movement. Currently, the factors and mechanisms contributing to impaired performance of these types of moveme